Total Payments
$611,544
2024 Payments
$76,707
Companies
29
Transactions
877
Medicare Patients
414
Medicare Billing
$50,866
Payment Breakdown by Category
Other$452,633 (74.0%)
Consulting$119,239 (19.5%)
Travel$17,300 (2.8%)
Food & Beverage$16,726 (2.7%)
Research$5,341 (0.9%)
Education$304.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $423,383 | 162 | 69.2% |
| Consulting Fee | $119,239 | 48 | 19.5% |
| Honoraria | $29,250 | 12 | 4.8% |
| Travel and Lodging | $17,300 | 99 | 2.8% |
| Food and Beverage | $16,726 | 538 | 2.7% |
| Unspecified | $5,341 | 8 | 0.9% |
| Education | $304.77 | 10 | 0.0% |
Payments by Type
General
$606,203
869 transactions
Research
$5,341
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $188,067 | 166 | $0 (2024) |
| Biogen, Inc. | $158,713 | 137 | $0 (2024) |
| Genentech USA, Inc. | $68,555 | 82 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $45,577 | 32 | $0 (2024) |
| Horizon Therapeutics plc | $41,364 | 58 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $34,620 | 45 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $23,689 | 37 | $0 (2024) |
| Celgene Corporation | $20,871 | 74 | $0 (2024) |
| Amgen Inc. | $17,179 | 20 | $0 (2024) |
| F. Hoffmann-La Roche AG | $4,026 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76,707 | 115 | Genentech USA, Inc. ($22,133) |
| 2023 | $72,589 | 123 | Horizon Therapeutics plc ($31,191) |
| 2022 | $66,000 | 140 | Biogen, Inc. ($25,058) |
| 2021 | $49,919 | 88 | Biogen, Inc. ($17,454) |
| 2020 | $34,441 | 63 | Celgene Corporation ($13,135) |
| 2019 | $62,215 | 112 | GENZYME CORPORATION ($22,433) |
| 2018 | $116,988 | 105 | GENZYME CORPORATION ($75,170) |
| 2017 | $132,685 | 131 | GENZYME CORPORATION ($60,514) |
All Payment Transactions
877 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,320.00 | General |
| 12/26/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| 12/18/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/18/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,450.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| 12/05/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $110.82 | General |
| 12/04/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | In-kind items and services | $556.69 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $91.17 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/27/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/25/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | In-kind items and services | $15.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| 11/20/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Medical Device | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,880.00 | General |
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.22 | General |
| 11/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Neurology | ||||||
| 10/27/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.63 | General |
| 10/26/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Consulting Fee | Cash or cash equivalent | $6,210.00 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | In-kind items and services | $616.00 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | In-kind items and services | $215.93 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $208.50 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Satralizumab Treatment in Adults With AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorder: A Retrospective Case Series | F. Hoffmann-La Roche AG | $2,029 | 1 |
| One-Year Analysis of Efficacy and Safety Data From Black/African American and Hispanic/Latino People With Relapsing Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial | F. Hoffmann-La Roche AG | $1,289 | 2 |
| One-Year Analysis of Ocrelizumab Treatment in Black/African American and Hispanic/Latino People With Relapsing Multiple Sclerosis From the CHIMES Trial | F. Hoffmann-La Roche AG | $707.93 | 1 |
| A Long-Term Follow-Up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS3409),An Extension Protocol for Multiple Scerlosis Patients Who Participated in Gen | GENZYME CORPORATION | $472.94 | 1 |
| A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab extension study (CAMMS03409) | GENZYME CORPORATION | $472.94 | 1 |
| A long-term follow up study for multiple sclerosis patients who have completed the alemtuzumab extension study | GENZYME CORPORATION | $187.06 | 1 |
| A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409) | GENZYME CORPORATION | $182.61 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 115 | 158 | $67,155 | $15,249 |
| 2022 | 3 | 102 | 135 | $54,085 | $12,369 |
| 2021 | 3 | 102 | 135 | $46,485 | $13,538 |
| 2020 | 4 | 95 | 124 | $42,080 | $9,710 |
Total Patients
414
Total Services
552
Medicare Billing
$50,866
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 68 | $29,515 | $6,976 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 33 | $20,030 | $4,808 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 57 | $17,610 | $3,465 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 58 | $25,200 | $5,853 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 60 | $18,530 | $3,904 | 21.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 17 | $10,355 | $2,612 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 64 | $23,680 | $6,484 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 51 | $13,005 | $4,060 | 31.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 20 | $9,800 | $2,994 | 30.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 65 | $24,050 | $5,674 | 23.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 30 | $7,650 | $1,788 | 23.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $7,590 | $1,547 | 20.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 17 | 18 | $2,790 | $699.99 | 25.1% |
About Dr. Krupa Pandey, M.D
Dr. Krupa Pandey, M.D is a Neurology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255501508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Krupa Pandey, M.D has received a total of $611,544 in payments from pharmaceutical and medical device companies, with $76,707 received in 2024. These payments were reported across 877 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($423,383).
As a Medicare-enrolled provider, Pandey has provided services to 414 Medicare beneficiaries, totaling 552 services with total Medicare billing of $50,866. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Albany, NY
- Active Since 03/03/2008
- Last Updated 07/14/2009
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1255501508
Products in Payments
- AUBAGIO (Drug) $104,375
- LEMTRADA (Drug) $63,650
- ZEPOSIA (Drug) $45,175
- TECFIDERA (Drug) $43,996
- UPLIZNA (Drug) $41,364
- COPAXONE (Drug) $34,398
- Ocrevus (Biological) $29,567
- TYSABRI (Biological) $29,046
- VUMERITY (Drug) $27,710
- OCREVUS (Biological) $24,665
- SOLIRIS (Drug) $9,976
- Tysabri (Biological) $6,843
- Non-Covered Product (Drug) $6,201
- UPLIZNA (Biological) $4,079
- AMPYRA (Drug) $2,589
- Enspryng (Biological) $2,080
- BRIUMVI (Drug) $1,807
- Soliris (Drug) $1,260
- KESIMPTA (Drug) $933.10
- GILENYA (Drug) $283.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Albany
Charles Argoff, Md, MD
Neurology — Payments: $1.6M
Neurology $1.6M
Mrs. Angela Applebee, M.d, M.D
Neurology — Payments: $690,780
Neurology $690,780
Dr. Stanley Penc, Md Phd, MD PHD
Neurology — Payments: $552,076
Neurology $552,076
Dr. Timothy Lynch, Md, MD
Neurology — Payments: $273,946
Neurology $273,946
Dr. Jennifer Durphy, M.d, M.D
Neurology — Payments: $117,071
Neurology $117,071
Richard Holub, Md, MD
Neurology — Payments: $113,635
Neurology $113,635